Literature DB >> 26464016

Hepatic Resection Improves Long-Term Survival of Patients with Large and/or Multinodular Hepatocellular Carcinoma.

Ling Deng1, Chun Yang2, Le-Qun Li1, Jian-Hong Zhong3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26464016     DOI： 10.1007/s11605-015-2965-2

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  13 in total

1.  Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  C Verslype; O Rosmorduc; P Rougier
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

Review 2.  Surgical treatment of hepatocellular carcinoma: expert consensus statement.

Authors:  William Jarnagin; William C Chapman; Steven Curley; Michael D'Angelica; Charles Rosen; Elijah Dixon; David Nagorney
Journal:  HPB (Oxford)       Date:  2010-06       Impact factor: 3.647

3.  Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours, or portal hypertension.

Authors:  Jian-Hong Zhong; Yang Ke; Yan-Yan Wang; Le-Qun Li
Journal:  Gut       Date:  2014-09-03       Impact factor: 23.059

Review 4.  Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis.

Authors:  Wei Liu; Jian-Guo Zhou; Yi Sun; Lei Zhang; Bao-Cai Xing
Journal:  J Gastrointest Surg       Date:  2015-05-06       Impact factor: 3.452

Review 5.  Treatment of intermediate-stage hepatocellular carcinoma.

Authors:  Alejandro Forner; Marine Gilabert; Jordi Bruix; Jean-Luc Raoul
Journal:  Nat Rev Clin Oncol       Date:  2014-08-05       Impact factor: 66.675

6.  Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma.

Authors:  Jian-hong Zhong; Yang Ke; Wen-feng Gong; Bang-de Xiang; Liang Ma; Xin-ping Ye; Tao Peng; Gui-sheng Xie; Le-qun Li
Journal:  Ann Surg       Date:  2014-08       Impact factor: 12.969

7.  Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.

Authors:  Takeaki Ishizawa; Kiyoshi Hasegawa; Taku Aoki; Michiro Takahashi; Yosuke Inoue; Keiji Sano; Hiroshi Imamura; Yasuhiko Sugawara; Norihiro Kokudo; Masatoshi Makuuchi
Journal:  Gastroenterology       Date:  2008-03-08       Impact factor: 22.682

Review 8.  Hepatocellular carcinoma: clinical frontiers and perspectives.

Authors:  Jordi Bruix; Gregory J Gores; Vincenzo Mazzaferro
Journal:  Gut       Date:  2014-02-14       Impact factor: 23.059

9.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

10.  Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension.

Authors:  Jian-Hong Zhong; Hang Li; Nan Xiao; Xin-Ping Ye; Yang Ke; Yan-Yan Wang; Liang Ma; Jie Chen; Xue-Mei You; Zhi-Yuan Zhang; Shi-Dong Lu; Le-Qun Li
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240
View more
  1 in total

Review 1.  Systematic review of partial hepatic resection to treat hepatic metastases in patients with gastric cancer.

Authors:  Di Long; Peng-Cheng Yu; Wei Huang; Yu-Long Luo; Sen Zhang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.